Immune Therapy of HPV-induced Cancers

NCT01462838 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Oryx GmbH & Co. KG